OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - Q4 2017 holdings

$5.64 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 290 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 5.9% .

 Value Shares↓ Weighting
 AEGERIONnote2$20,695,000,000
+0.1%
26,000,0000.0%0.37%
+22.3%
TPGHU  TPG PACEunit9$10,330,000,000
+0.3%
1,000,0000.0%0.18%
+22.0%
 GOODRICHdebt1$3,097,000,000
+13.2%
4,874,9990.0%0.06%
+37.5%
 OREXIGENnote2$2,780,000,000
-7.3%
7,500,0000.0%0.05%
+11.4%
 OREXIGENnote2$2,550,000,000
-15.0%
7,500,0000.0%0.04%
+2.3%
 ALLSCRIPnote1$1,073,000,000
+1.0%
1,000,0000.0%0.02%
+26.7%
 BIOMARINnote0$1,087,000,000
-3.0%
1,000,0000.0%0.02%
+18.8%
 ILLUMINAnote6$1,090,000,000
+2.8%
1,000,0000.0%0.02%
+26.7%
 INFINERAdbcv1$991,000,000
-3.5%
1,000,0000.0%0.02%
+20.0%
 TWITTERnote0$958,000,000
+0.8%
1,000,0000.0%0.02%
+21.4%
 NUANCE Cdbcv1$959,000,000
+1.9%
1,000,0000.0%0.02%
+21.4%
 ACORDA Tnote1$852,000,000
-6.2%
1,000,0000.0%0.02%
+15.4%
THC  TENET HE$758,000,000
-7.8%
50,0000.0%0.01%
+8.3%
GCVRZ  SANOFIright$470,000,000
+5.4%
1,238,0770.0%0.01%
+33.3%
PLX  PROTALIX$215,000,000
+14.4%
324,4790.0%0.00%
+33.3%
CYHHZ  COMMUNITright$36,000,000
-39.0%
5,055,6770.0%0.00%0.0%
OREXQ  OREXIGEN$033,3330.0%0.00%
WIN  WINDSTREput$5,000,000
-77.3%
254,0000.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
  • View 13F-HR/A filed 2018-05-14
  • View 13F-HR/A filed 2018-08-15
  • View 13F-HR/A filed 2018-11-14
  • View 13F-HR/A filed 2019-02-19
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATF36Q3 20232.3%
SPDR S&P 533Q3 20230.7%
ACTIVISION29Q3 202371.3%
AMAZON COM29Q3 20230.8%
GAMING & L29Q3 20230.8%
SPDR S&P29Q1 20230.1%
DISNEY W28Q3 20212.0%
POST HLD27Q2 20201.8%
GENERAL27Q3 20221.4%
CAMDEN PPT27Q3 20230.6%

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.

Latest significant ownerships (13-D/G)
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) Q4 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/Sold outFebruary 13, 202300.0%
MAGELLAN HEALTH INCSold outFebruary 13, 202300.0%
New Providence Acquisition Corp. IIFebruary 13, 20232,227,5008.9%
Nuance Communications, Inc.Sold outFebruary 13, 202300.0%
SCP & CO Healthcare Acquisition CoSold outFebruary 13, 202300.0%
ACORDA THERAPEUTICS INCSold outFebruary 14, 202200.0%
Amryt Pharma plcFebruary 14, 20229,950,0003.1%
Evolv Technologies Holdings, Inc.February 14, 20221,547,3111.1%
GreenSky, Inc.February 14, 2022698,5530.8%
GTY Technology Holdings Inc.February 14, 2022758,0001.3%

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-06-06
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR2024-05-15
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (5644478000.0 != 5644478000000.0)
  • The reported has been amended

Export OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings